Citigroup
DRTX

Citigroup’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Citigroup’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-25,000
Closed -$317K – 7628
2014
Q3 		$317K Hold
25,000
– – ﹤0.01% 3890
2014
Q2 		$426K Buy
+25,000
New +$372K ﹤0.01% 3569

Citigroup's DRTX Position: Q4 2014 in Review

Citigroup sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 540 shares — an estimated $7K sold.

Citigroup first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $80K in Q4 2013. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Citigroup reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Citigroup sold 540 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $7K.
  • Citigroup first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Citigroup's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $80K in Q4 2013.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Citigroup's 13F filing for Q4 2014, filed 17 Feb 2015.